Factor XI: Hemostasis, thrombosis, and antithrombosis

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages 541-550

  He, Rong ^a   Chen, Dong ^a   He, Shilin ^b  

^a MAYO CLINIC   (United States)

^b Central South University   (China)

Author keywords

anticoagulants; deep vein thrombosis; Factor XI; FXI deficiency; thrombosis

Indexed keywords

4 AMINOBENZAMIDINE; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN; APROTININ; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR CONCENTRATE; COMPLEMENT COMPONENT C1S INHIBITOR; DESMOPRESSIN; FRESH FROZEN PLASMA; HEPARIN; LEUPEPTIN; PROTEASE NEXIN I; SERINE PROTEINASE INHIBITOR; THROMBIN; TRANEXAMIC ACID; WARFARIN;

ANTICOAGULATION; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL FEATURE; GENE MUTATION; GENE SILENCING; HEMOSTASIS; HUMAN; LOW DRUG DOSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; THROMBOPHILIA; THROMBOPLASTIN TIME; THROMBOSIS;

ANIMALS; ANTICOAGULANTS; FACTOR XI; HEMOSTASIS; HUMANS; THROMBOSIS;

EID: 84860479978     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.11.051     Document Type: Review

References (162)

1. E.W. Davie, K. Fujikawa, and W. Kisiel The coagulation cascade: initiation, maintenance, and regulation Biochemistry 30 1991 10363 10370
2. D. Gailani, and G.J. Broze Jr. Factor XI activation in a revised model of blood coagulation Science 253 1991 909 912
3. D.V. Kravtsov, A. Matafonov, E.I. Tucker, M.F. Sun, P.N. Walsh, and A. Gruber Factor XI contributes to thrombin generation in the absence of factor XII Blood 114 2009 452 458
4. O. Salomon, D.M. Steinberg, M. Zucker, D. Varon, A. Zivelin, and U. Seligshon Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis Thromb Haemost 105 2011 269 273
5. O. Salomon, D.M. Steinberg, N. Koren-Morag, D. Tanne, and U. Seligsohn Reduced incidence of ischemic stroke in patients with severe factor XI deficiency Blood 111 2008 4113 4117
6. E.D. Rosen, D. Gailani, and F.J. Castellino FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse Thromb Haemost 87 2002 774 776
7. X. Wang, P.L. Smith, M.Y. Hsu, D. Gailani, W.A. Schumacher, and M.L. Ogletree Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice J Thromb Haemost 4 2006 1982 1988
8. X. Wang, Q. Cheng, L. Xu, G.Z. Feuerstein, M.Y. Hsu, and P.L. Smith Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice J Thromb Haemost 3 2005 695 702
9. J.C. Meijers, W.L. Tekelenburg, B.N. Bouma, R.M. Bertina, and F.R. Rosendaal High levels of coagulation factor XI as a risk factor for venous thrombosis N Engl J Med 342 2000 696 701
10. M.B. Ponczek, D. Gailani, and R.F. Doolittle Evolution of the contact phase of vertebrate blood coagulation J Thromb Haemost 6 2008 1876 1883
11. N. Mackman Tissue-specific hemostasis in mice Arterioscler Thromb Vasc Biol 25 2005 2273 2281
12. Q. Cheng, J. Kantz, G. Poffenberger, A.C. Powers, and D. Gailani Factor XI protein in human pancreas and kidney Thromb Haemost 100 2008 158 160
13. T. Tarumi, D.V. Kravtsov, M. Zhao, S.M. Williams, and D. Gailani Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha) is required for hepatocyte-specific expression of factor XI J Biol Chem 277 2002 18510 18516
14. D. Gailani, A. Zivelin, D. Sinha, and P.N. Walsh Do platelets synthesize factor XI? J Thromb Haemost 2 2004 1709 1712
15. H.I. Horowitz, and M.M. Fujimoto Association of Factors Xi and Xii with Blood Platelets Proc Soc Exp Biol Med 119 1965 487 492
16. P.N. Walsh Albumin density gradient separation and washing of platelets and the study of platelet coagulant activities Br J Haematol 22 1972 205 217
17. J.M. Connellan, P.A. Castaldi, and R.H. Muntz The role of factor XI in the coagulant activity of platelets Haemostasis 6 1977 41 52
18. M.S. Lipscomb, and P.N. Walsh Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI J Clin Invest 63 1979 1006 1014
19. D.E. Macfarlane, P.N. Walsh, D.C. Mills, H. Holmsen, and H.J. Day The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation Br J Haematol 30 1975 457 463
20. G.P. Tuszynski, S.J. Bevacqua, A.H. Schmaier, R.W. Colman, and P.N. Walsh Factor XI antigen and activity in human platelets Blood 59 1982 1148 1156
21. S. Schiffman, and C.H. Yeh Purification and characterization of platelet factor XI Thromb Res 60 1990 87 97
22. T.C. Hsu, S.K. Shore, T. Seshsmma, O. Bagasra, and P.N. Walsh Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene J Biol Chem 273 1998 13787 13793
23. D. Martincic, V. Kravtsov, and D. Gailani Factor XI messenger RNA in human platelets Blood 94 1999 3397 3404
24. A. Podmore, M. Smith, G. Savidge, and A. Alhaq Real-time quantitative PCR analysis of factor XI mRNA variants in human platelets J Thromb Haemost 2 2004 1713 1719
25. E. Berber Molecular characterization of FXI deficiency Clin Appl Thromb Hemost 17 2011 27 32
26. M. Andrew, B. Paes, R. Milner, M. Johnston, L. Mitchell, and D.M. Tollefsen Development of the human coagulation system in the full-term infant Blood 70 1987 165 172
27. D.J. Brotman, J.P. Girod, A. Posch, J.T. Jani, J.V. Patel, and M. Gupta Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers Thromb Res 118 2006 247 252
28. R.E. Thompson, R. Mandle Jr., and A.P. Kaplan Association of factor XI and high molecular weight kininogen in human plasma J Clin Invest 60 1977 1376 1380
29. K. Kurachi, K. Fujikawa, and E.W. Davie Mechanism of activation of bovine factor XI by factor XII and factor XIIa Biochemistry 19 1980 1330 1338
30. K. Gomez, and P. Bolton-Maggs Factor XI deficiency Haemophilia 14 2008 1183 1189
31. J.S. Greengard, M.J. Heeb, E. Ersdal, P.N. Walsh, and J.H. Griffin Binding of coagulation factor XI to washed human platelets Biochemistry 25 1986 3884 3890
32. F.A. Baglia, B.A. Jameson, and P.N. Walsh Identification and characterization of a binding site for platelets in the Apple 3 domain of coagulation factor XI J Biol Chem 270 1995 6734 6740
33. F.A. Baglia, D. Gailani, J.A. Lopez, and P.N. Walsh Identification of a binding site for glycoprotein Ibalpha in the Apple 3 domain of factor XI J Biol Chem 279 2004 45470 45476
34. K. Fujikawa, D.W. Chung, L.E. Hendrickson, and E.W. Davie Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein Biochemistry 25 1986 2417 2424
35. E. Papagrigoriou, P.A. McEwan, P.N. Walsh, and J. Emsley Crystal structure of the factor XI zymogen reveals a pathway for transactivation Nat Struct Mol Biol 13 2006 557 558
36. F.A. Baglia, and P.N. Walsh A binding site for thrombin in the apple 1 domain of factor XI J Biol Chem 271 1996 3652 3658
37. T. Renne, D. Gailani, J.C. Meijers, and W. Muller-Esterl Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein J Biol Chem 277 2002 4892 4899
38. M.F. Sun, M. Zhao, and D. Gailani Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX J Biol Chem 274 1999 36373 36378
39. D.H. Ho, K. Badellino, F.A. Baglia, and P.N. Walsh A binding site for heparin in the apple 3 domain of factor XI J Biol Chem 273 1998 16382 16390
40. M. Zhao, T. Abdel-Razek, M.F. Sun, and D. Gailani Characterization of a heparin binding site on the heavy chain of factor XI J Biol Chem 273 1998 31153 31159
41. F.A. Baglia, B.A. Jameson, and P.N. Walsh Identification and characterization of a binding site for factor XIIa in the Apple 4 domain of coagulation factor XI J Biol Chem 268 1993 3838 3844
42. J. Emsley, P.A. McEwan, and D. Gailani Structure and function of factor XI Blood 115 2010 2569 2577
43. F.A. Baglia, B.A. Jameson, and P.N. Walsh Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86 J Biol Chem 265 1990 4149 4154
44. B.A. McMullen, K. Fujikawa, and E.W. Davie Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains Biochemistry 30 1991 2056 2060
45. W. Wu, D. Sinha, S. Shikov, C.K. Yip, T. Walz, and P.C. Billings Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa J Biol Chem 283 2008 18655 18664
46. M. Zucker, A. Zivelin, M. Landau, N. Rosenberg, and U. Seligsohn Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI J Thromb Haemost 7 2009 970 975
47. B.N. Bouma, and J.H. Griffin Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII J Biol Chem 252 1977 6432 6437
48. K. Naito, and K. Fujikawa Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces J Biol Chem 266 1991 7353 7358
49. P.A. von dem Borne, L.O. Mosnier, G. Tans, J.C. Meijers, and B.N. Bouma Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine Thromb Haemost 78 1997 834 839
50. P.A. von dem Borne, J.C. Meijers, and B.N. Bouma Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis Blood 86 1995 3035 3042
51. S.H. Choi, S.A. Smith, and J.H. Morrissey Polyphosphate is a cofactor for the activation of factor XI by thrombin Published online before print, Blood 2011 Oct. 5
52. I.M. Keularts, A. Zivelin, U. Seligsohn, H.C. Hemker, and S. Beguin The role of factor XI in thrombin generation induced by low concentrations of tissue factor Thromb Haemost 85 2001 1060 1065
53. R. He, S. Xiong, X. He, F. Liu, J. Han, and J. Li The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway Thromb Haemost 85 2001 1055 1059
54. K.M. Cawthern, C. van 't Veer, J.B. Lock, M.E. DiLorenzo, R.F. Branda, and K.G. Mann Blood coagulation in hemophilia A and hemophilia C Blood 91 1998 4581 4592
55. D.L. Pedicord, D. Seiffert, and Y. Blat Feedback activation of factor XI by thrombin does not occur in plasma Proc Natl Acad Sci U S A 104 2007 12855 12860
56. A. Matafonov, S. Sarilla, M.F. Sun, J.P. Sheehan, V. Serebrov, and I.M. Verhamme Activation of factor XI by products of prothrombin activation Blood 118 2011 437 445
57. T. Renne, M. Pozgajova, S. Gruner, K. Schuh, H.U. Pauer, and P. Burfeind Defective thrombus formation in mice lacking coagulation factor XII J Exp Med 202 2005 271 281
58. T. Renne, B. Nieswandt, and D. Gailani The intrinsic pathway of coagulation is essential for thrombus stability in mice Blood Cells Mol Dis 36 2006 148 151
59. C. Kleinschnitz, G. Stoll, M. Bendszus, K. Schuh, H.U. Pauer, and P. Burfeind Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis J Exp Med 203 2006 513 518
60. I. Schousboe Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation Biochem Pharmacol 75 2008 1007 1013
61. Q. Cheng, E.I. Tucker, M.S. Pine, I. Sisler, A. Matafonov, and M.F. Sun A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo Blood 116 2010 3981 3989
62. U. Seligsohn Factor XI in haemostasis and thrombosis: past, present and future Thromb Haemost 98 2007 84 89
63. D. Gailani, and S.B. Smith Structural and functional features of factor XI J Thromb Haemost 7 Suppl. 1 2009 75 78
64. S.B. Smith, and D. Gailani Update on the physiology and pathology of factor IX activation by factor XIa Expert Rev Hematol 1 2008 87 98
65. S.B. Smith, I.M. Verhamme, M.F. Sun, P.E. Bock, and D. Gailani Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation J Biol Chem 283 2008 6696 6705
66. J.A. Oliver, D.M. Monroe, H.R. Roberts, and M. Hoffman Thrombin activates factor XI on activated platelets in the absence of factor XII Arterioscler Thromb Vasc Biol 19 1999 170 177
67. S.J. Wielders, S. Beguin, H.C. Hemker, and T. Lindhout Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available Arterioscler Thromb Vasc Biol 24 2004 1138 1142
68. F.A. Baglia, and P.N. Walsh Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin Biochemistry 37 1998 2271 2281
69. P.N. Walsh Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor-XI activation by thrombin Biochemistry 46 2007 12886 12887
70. M.T. Pennings, R.H. Derksen, M. van Lummel, J. Adelmeijer, K. VanHoorelbeke, and R.T. Urbanus Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2' J Thromb Haemost 5 2007 369 377
71. C. Maas, J.C. Meijers, J.A. Marquart, K. Bakhtiari, C. Weeterings, and P.G. de Groot Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma Proc Natl Acad Sci U S A 107 2010 9083 9087
72. T. Shi, G.M. Iverson, J.C. Qi, K.A. Cockerill, M.D. Linnik, and P. Konecny Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I Proc Natl Acad Sci U S A 101 2004 3939 3944
73. J.C. Meijers, E.W. Davie, and D.W. Chung Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency Blood 79 1992 1435 1440
74. D. Gailani, D. Ho, M.F. Sun, Q. Cheng, and P.N. Walsh Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential Blood 97 2001 3117 3122
75. A. Aktimur, M.A. Gabriel, D. Gailani, and J.R. Toomey The factor IX gamma-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa J Biol Chem 278 2003 7981 7987
76. A.S. Wolberg, D.P. Morris, and D.W. Stafford Factor IX activation by factor XIa proceeds without release of a free intermediate Biochemistry 36 1997 4074 4079
77. M.F. Whelihan, T. Orfeo, M.T. Gissel, and K.G. Mann Coagulation procofactor activation by factor XIa J Thromb Haemost 8 2010 1532 1539
78. P.A. von dem Borne, L.M. Cox, and B.N. Bouma Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor Blood Coagul Fibrinolysis 17 2006 251 257
79. C. Carrieri, R. Galasso, F. Semeraro, C.T. Ammollo, N. Semeraro, and M. Colucci The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood J Thromb Haemost 9 2011 154 162
80. L. Yang, M.F. Sun, D. Gailani, and A.R. Rezaie Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor Biochemistry 48 2009 1517 1524
81. W.A. Wuillemin, C.E. Hack, W.K. Bleeker, B.J. Biemond, M. Levi, and H. ten Cate Inactivation of factor Xia in vivo: studies in chimpanzees and in humans Thromb Haemost 76 1996 549 555
82. J. Zhang, Y. Tu, L. Lu, N. Lasky, and G.J. Broze Jr. Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency Blood 111 2008 4973 4978
83. J.M. Scandura, Y. Zhang, W.E. Van Nostrand, and P.N. Walsh Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2 Biochemistry 36 1997 412 420
84. D. Navaneetham, L. Jin, P. Pandey, J.E. Strickler, R.E. Babine, and S.S. Abdel-Meguid Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2 J Biol Chem 280 2005 36165 36175
85. R.L. Rosenthal, O.H. Dreskin, and N. Rosenthal New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor Proc Soc Exp Biol Med 82 1953 171 174
86. R.E. Saunders, N. Shiltagh, K. Gomez, G. Mellars, C. Cooper, and D.J. Perry Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency Thromb Haemost 102 2009 287 301
87. O. Shpilberg, H. Peretz, A. Zivelin, R. Yatuv, A. Chetrit, and T. Kulka One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews Blood 85 1995 429 432
88. R. Asakai, E.W. Davie, and D.W. Chung Organization of the gene for human factor XI Biochemistry 26 1987 7221 7228
89. A. Kato, R. Asakai, E.W. Davie, and N. Aoki Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4 Cytogenet Cell Genet 52 1989 77 78
90. U. Seligsohn Factor XI deficiency in humans J Thromb Haemost 7 Suppl. 1 2009 84 87
91. R. Asakai, D.W. Chung, E.W. Davie, and U. Seligsohn Factor XI deficiency in Ashkenazi Jews in Israel N Engl J Med 325 1991 153 158
92. J.F. Hancock, K. Wieland, R.E. Pugh, U. Martinowitz, S. Schulman, and V.V. Kakkar A molecular genetic study of factor XI deficiency Blood 77 1991 1942 1948
93. H. Peretz, A. Mulai, S. Usher, A. Zivelin, A. Segal, and Z. Weisman The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin Blood 90 1997 2654 2659
94. D.B. Goldstein, D.E. Reich, N. Bradman, S. Usher, U. Seligsohn, and H. Peretz Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews Am J Hum Genet 64 1999 1071 1075
95. P.H. Bolton-Maggs, H. Peretz, R. Butler, R. Mountford, S. Keeney, and L. Zacharski A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency J Thromb Haemost 2 2004 918 924
96. A. Zivelin, F. Bauduer, L. Ducout, H. Peretz, N. Rosenberg, and R. Yatuv Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene Blood 99 2002 2448 2454
97. F. Quelin, M. Trossaert, M. Sigaud, P.D. Mazancourt, and E. Fressinaud Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation J Thromb Haemost 2 2004 71 76
98. W.M. Wu, H.L. Wang, X.F. Wang, H.Y. Chu, Q.H. Fu, and Q.L. Ding Identification of two novel factor XI non-sense mutation Trp228stop and Trp383stop in a Chinese pedigree of congenital factor XI deficiency Zhonghua Xue Ye Xue Za Zhi 24 2003 126 128
99. K. Okumura, M. Kyotani, R. Kawai, A. Takagi, T. Murate, and K. Yamamoto Recurrent mutations of factor XI gene in Japanese Int J Hematol 83 2006 462 463
100. E.M. Duncan, G.J. Casey, M.P. Fenech, N.V. Lerda, C.R. Casey, and S.E. Rodgers Partial and severe factor XI deficiency in South Australia and the usefulness of factor XI mutation analysis for diagnosis Pathology 40 2008 401 406
101. F. Peyvandi, R. Palla, M. Menegatti, and P.M. Mannucci Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management Semin Thromb Hemost 35 2009 349 355
102. D.V. Kravtsov, P.E. Monahan, and D. Gailani A classification system for cross-reactive material-negative factor XI deficiency Blood 105 2005 4671 4673
103. P.H. Bolton-Maggs Factor XI deficiency - resolving the enigma? Hematology Am Soc Hematol Educ Program 2009 97 105
104. R.E. Saunders, N.M. O'Connell, C.A. Lee, D.J. Perry, and S.J. Perkins Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools Hum Mutat 26 2005 192 198
105. N.M. O'Connell, R.E. Saunders, C.A. Lee, D.J. Perry, and S.J. Perkins Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling J Thromb Haemost 3 2005 127 138
106. C. Bozzao, V. Rimoldi, R. Asselta, M. Landau, R. Ghiotto, and M.L. Tenchini A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency FEBS J 274 2007 6128 6138
107. M.F. Sun, F.A. Baglia, D. Ho, D. Martincic, R.E. Ware, and P.N. Walsh Defective binding of factor XI-N248 to activated human platelets Blood 98 2001 125 129
108. I. Guella, G. Solda, S. Spena, R. Asselta, R. Ghiotto, and M.L. Tenchini Molecular characterization of two novel mutations causing factor XI deficiency: A splicing defect and a missense mutation responsible for a CRM + defect Thromb Haemost 99 2008 523 530
109. M. Mitchell, J. Cutler, S. Thompson, G. Moore, E. Jenkins Ap Rees, and M. Smith Heterozygous factor XI deficiency associated with three novel mutations Br J Haematol 107 1999 763 765
110. A. Zivelin, T. Ogawa, S. Bulvik, M. Landau, J.R. Toomey, and J. Lane Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation J Thromb Haemost 2 2004 1782 1789
111. M. Germanos-Haddad, P. de Moerloose, F. Boehlen, F. Peyvandi, and M. Neerman-Arbez Homozygosity for a Thr575Met missense mutation in the catalytic domain associated with factor XI deficiency Haematologica 90 2005 418 419
112. M.J. Mitchell, L. Dai, J.B. Clarke, P.H. Bolton-Maggs, G.F. Savidge, and A. Alhaq Characterisation of five factor XI mutations Thromb Haemost 97 2007 884 889
113. D. Gailani, A. Schmidt, M.F. Sun, P.H. Bolton-Maggs, and S.P. Bajaj A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect J Thromb Haemost 5 2007 781 787
114. M.V. Ragni, D. Sinha, F. Seaman, J.H. Lewis, J.A. Spero, and P.N. Walsh Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds Blood 65 1985 719 724
115. P.H. Bolton-Maggs, D.A. Patterson, R.T. Wensley, and E.G. Tuddenham Definition of the bleeding tendency in factor XI-deficient kindreds-a clinical and laboratory study Thromb Haemost 73 1995 194 202
116. L. Rugeri, F. Quelin, B. Chatard, P. De Mazancourt, C. Negrier, and Y. Dargaud Thrombin generation in patients with factor XI deficiency and clinical bleeding risk Haemophilia 16 2010 771 777
117. G. Kenet, A. Lubetsky, J. Luboshitz, B. Ravid, I. Tamarin, and D. Varon Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors Haemophilia 15 2009 1065 1073
118. N.M. O'Connell, A.F. Riddell, G. Pascoe, D.J. Perry, and C.A. Lee Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency Haemophilia 14 2008 775 781
119. T. Livnat, I. Tamarin, Y. Mor, H. Winckler, Z. Horowitz, and Y. Korianski Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies Thromb Haemost 102 2009 487 492
120. O. Salomon, D.M. Steinberg, and U. Seligshon Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy Haemophilia 12 2006 490 493
121. M. Franchini, F. Manzato, G.L. Salvagno, M. Montagnana, and G. Lippi The use of desmopressin in congenital factor XI deficiency: a systematic review Ann Hematol 88 2009 931 935
122. A. Gruber, and S.R. Hanson Potential new targets for antithrombotic therapy Curr Pharm Des 9 2003 2367 2374
123. M. Menegatti, and F. Peyvandi Factor X deficiency Semin Thromb Hemost 35 2009 407 415
124. R. Asselta, and F. Peyvandi Factor V deficiency Semin Thromb Hemost 35 2009 382 389
125. S. Lancellotti, and R. De Cristofaro Congenital prothrombin deficiency Semin Thromb Hemost 35 2009 367 381
126. N. Mackman, R.E. Tilley, and N.S. Key Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis Arterioscler Thromb Vasc Biol 27 2007 1687 1693
127. G. Mariani, and F. Bernardi Factor VII Deficiency Semin Thromb Hemost 35 2009 400 406
128. H.U. Pauer, T. Renne, B. Hemmerlein, T. Legler, S. Fritzlar, and I. Adham Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo Thromb Haemost 92 2004 503 508
129. A. Girolami, E. Ruzzon, A.M. Lombardi, L. Cabrio, and M.L. Randi Thrombosis-free surgical procedures in severe (Homozygote) factor XII deficiency: report of four additional cases and literature review Clin Appl Thromb Hemost 10 2004 351 355
130. D. Gailani, and T. Renne The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost 5 2007 1106 1112
131. W.A. Schumacher, J.M. Luettgen, M.L. Quan, and D.A. Seiffert Inhibition of factor XIa as a new approach to anticoagulation Arterioscler Thromb Vasc Biol 30 2010 388 392
132. E.C. Lowenberg, J.C. Meijers, B.P. Monia, and M. Levi Coagulation factor XI as a novel target for antithrombotic treatment J Thromb Haemost 8 2010 2349 2357
133. T. Renne, C. Oschatz, S. Seifert, F. Muller, J. Antovic, and M. Karlman Factor XI deficiency in animal models J Thromb Haemost 7 Suppl. 1 2009 79 83
134. S. Eichinger, V. Schonauer, A. Weltermann, E. Minar, C. Bialonczyk, and M. Hirschl Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism Blood 103 2004 3773 3776
135. D.T. Yang, M.M. Flanders, H. Kim, and G.M. Rodgers Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events Am J Clin Pathol 126 2006 411 415
136. B. Tanis, A. Algra, Y. van der Graaf, F. Helmerhorst, and F. Rosendaal Procoagulant factors and the risk of myocardial infarction in young women Eur J Haematol 77 2006 67 73
137. C. Merlo, W.A. Wuillemin, M. Redondo, M. Furlan, I. Sulzer, and J. Kremer-Hovinga Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease Atherosclerosis 161 2002 261 267
138. S. Butenas, A. Undas, M.T. Gissel, K. Szuldrzynski, K. Zmudka, and K.G. Mann Factor XIa and tissue factor activity in patients with coronary artery disease Thromb Haemost 99 2008 142 149
139. C.J. Doggen, F.R. Rosendaal, and J.C. Meijers Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII Blood 108 2006 4045 4051
140. O. Salomon, D.M. Steinberg, R. Dardik, N. Rosenberg, A. Zivelin, and I. Tamarin Inherited factor XI deficiency confers no protection against acute myocardial infarction J Thromb Haemost 1 2003 658 661
141. R.D. Rosenberg, and W.C. Aird Vascular-bed-specific hemostasis and hypercoagulable states N Engl J Med 340 1999 1555 1564
142. W.C. Aird Vascular bed-specific thrombosis J Thromb Haemost 5 Suppl. 1 2007 283 291
143. D. Gailani, N.M. Lasky, and G.J. Broze Jr. A murine model of factor XI deficiency Blood Coagul Fibrinolysis 8 1997 134 144
144. T.R. Baird, D. Gailani, B. Furie, and B.C. Furie Factor XI deficient mice have reduced platelet accumulation and fibrin deposition after laser injury Blood 104 2004 66a-a
145. J.C. Chan, J.G. Ganopolsky, I. Cornelissen, M.A. Suckow, M.J. Sandoval-Cooper, and E.C. Brown The characterization of mice with a targeted combined deficiency of protein c and factor XI Am J Pathol 158 2001 469 479
146. M.C. Minnema, P.W. Friederich, M. Levi, P.A. von dem Borne, L.O. Mosnier, and J.C. Meijers Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor J Clin Invest 101 1998 10 14
147. P. Kraft, T. Schwarz, J.C. Meijers, G. Stoll, and C. Kleinschnitz Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke PLoS One 5 2010 e11658
148. E.I. Tucker, D. Gailani, S. Hurst, Q. Cheng, S.R. Hanson, and A. Gruber Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis J Infect Dis 198 2008 271 274
149. A. Gruber, and S.R. Hanson Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates Blood 102 2003 953 955
150. E.I. Tucker, U.M. Marzec, T.C. White, S. Hurst, S. Rugonyi, and O.J. McCarty Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI Blood 113 2009 936 944
151. A. Yamashita, K. Nishihira, T. Kitazawa, K. Yoshihashi, T. Soeda, and K. Esaki Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery J Thromb Haemost 4 2006 1496 1501
152. M. Takahashi, A. Yamashita, S. Moriguchi-Goto, C. Sugita, T. Matsumoto, and S. Matsuda Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis Thromb Res 125 2010 464 470
153. H. Zhang, E.C. Lowenberg, J.R. Crosby, A.R. MacLeod, C. Zhao, and D. Gao Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk Blood 116 2010 4684 4692
154. I.T. Campos, A.M. Tanaka-Azevedo, and A.S. Tanaka Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae) FEBS Lett 577 2004 512 516
155. I. Hagedorn, S. Schmidbauer, I. Pleines, C. Kleinschnitz, U. Kronthaler, and G. Stoll Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding Circulation 121 2010 1510 1517
156. S. Robert, C. Bertolla, B. Masereel, J.M. Dogne, and L. Pochet Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors J Med Chem 51 2008 3077 3080
157. P. Kraft, T. Schwarz, L. Pochet, G. Stoll, and C. Kleinschnitz COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke Exp Transl Stroke Med 2 2010 5
158. J. Lin, H. Deng, L. Jin, P. Pandey, J. Quinn, and S. Cantin Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants J Med Chem 49 2006 7781 7791
159. H. Deng, T.D. Bannister, L. Jin, R.E. Babine, J. Quinn, and P. Nagafuji Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an alpha-ketothiazole arginine Bioorg Med Chem Lett 16 2006 3049 3054
160. W.A. Schumacher, S.E. Seiler, T.E. Steinbacher, A.B. Stewart, J.S. Bostwick, and K.S. Hartl Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats Eur J Pharmacol 570 2007 167 174
161. D. Li, Q. He, T. Kang, H. Yin, X. Jin, and H. Li Identification of an anticoagulant peptide that inhibits both fXIa and fVIIa/tissue factor from the blood-feeding nematode Ancylostoma caninum Biochem Biophys Res Commun 392 2010 155 159
162. Y. Decrem, G. Rath, V. Blasioli, P. Cauchie, S. Robert, and J. Beaufays Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis J Exp Med 206 2009 2381 2395